Table 6 Prevalence of Sarcopenia reported by studies in the last two decades
From: Prevalence of sarcopenia in community dwelling outpatient postmenopausal Hungarian women
Study | Year | Country | Male/Female | Age, years mean (SD) [Range] | Assesment method | Sarcopenia prevalence, % | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Muscle mass | Muscle strength | Physical performance | Total | Male | Female | |||||
Landi et al. [6] | 2012 | Italy | 31/91 | 84.1 (4.8) [70+] | BIA | HGS | GS | 32.8 | 67.7 | 20.8 |
Sanada et al. [7] | 2012 | Japan | 0/533 | [30–84] | DXA | HGS, LEP | Sit and reach, VO2 max | 24.2 | – | 24.2 |
Tanimoto et al. [8] | 2012 | Japan | 364/794 | F: 73.9 (6.3) [65+] | BIA | HGS | GS | – | 11.3 | 10.7 |
Abellan van Kan et al. [9] | 2013 | France | 0/3025 | 80.51 (3.9) [≥75] | DXA | HGS | GS | 5.2 | – | 5.2 |
Verschueren et al. [10] | 2013 | Belgium, UK | 679/0 | 59.6 (10.7) [40–79] | DXA | HGS, IIS | GS | 3.7 | 3.7 | – |
Patil et al. [11] | 2013 | Finland | 0/409 | 74.2 (3.0) [70–80] | DXA | HGS | SPPB (4MGS, TUG, SB) | 0.9–2.7 | – | 0.9 |
Landi et al. [12] | 2013 | Italy | 118/236 | 85.8 (4.9) | MAMC | HGS | 4MGS | 29.1 | 27.1 | 19.8 |
Malmstrom et al. [13] | 2013 | USA | 124/195 | 59.2 (4.4) | DXA | not included | 4MGS, 6MWT | 4.1 | – | – |
Legrand et al. [14] | 2013 | Belgium | 103/185 | 84.8 (3.6) [> 80] | BIA | HGS | mSPPB, GS | 12.5 | 14.6 | 12.4 |
Yamada et al. [15] | 2013 | Japan | 568/1314 | 74.9 (5.5) [65–89] | BIA | HGS | 10MGS | 22 | 21.8 | 22.1 |
McIntosh et al. [16] | 2013 | Canada | 42/43 | 75.2 (5.7) | BIA | HGS | DGI | 6 | 5 | 7 |
Volpato et al. [17] | 2014 | Italy | 250/288 | 77.1 (5.5) [65–89] | BIA | HGS | 4MGS | 10.2 | 7.6 | 12.5 |
Murphy et al. [18] | 2014 | USA | 1426/1502 | F: 73.8 (2.85) | DXA | HGS | GS | 5 | – | – |
Jones et al. [19] | 2015 | UK | 354/268 | 70.35 (9.2) | BIA | HGS | 4MGS | 14.5 | 11.8 | 17.4 |
Mijnarends et al. [20] | 2016 | Neatherlands | 117/110 | 74.9 (7.2) | BIA | HGS | 4MGS | 23.3 | 23.9 | 22.7 |
Wang et al. [21] | 2016 | China | 190/65 | 65.1 (10.85) | L3 TAMA | HGS | 6MGS | 12.5 | 13.7 | 9.2 |
Sousa et al. [22] | 2016 | Portugal | 354/302 | 56 (22) | BIA | HGS | not included | 24.2 | 28.5 | 19.2 |
Gani et al. [23] | 2016 | USA | 608/561 | 62 [52–70] | L3 TPV | not included | not included | 25.1 | 25 | 25.1 |
Wang et al. [24] | 2016 | China | 462/482 | 69.02 (6.3) [60–92] | DXA, BIA | HGS | 6MGS | 10.4 | 8.2 | 12.5 |
Dorosty et al. [25] | 2016 | Iran | 310/334 | 70.8 (6.1) | BIA | HGS | 6MGS | 16.5 | 21.3 | 8.9 |
Diz et al. [26] | 2017 | Brazil | 2927/6459 | 83.4 (2.9) | DXA | not included | not included | 17 | 12 | 20 |
Tramontano et al. [27] | 2017 | Peru | 102/120 | [65+] | BIA | not included | SPPB, 6MWT | 17.6 | 0.01 | 31.7 |
Lou et al. [28] | 2017 | China | 161/45 | 64 (10.1) | L3 TAMA | HGS | 6MGS | 6.8 | 5.6 | 11.1 |
Antunes et al. [29] | 2017 | Portugal | 82/119 | [65+] | MUAMC, MAMC | HGS | TUG | 10.4 | 17.1 | 5.9 |
Kaplan et al. [30] | 2017 | USA | 269/181 | 76 (68–89) | L3 TAMA | not included | not included | 53.5 | 60.6 | 43.1 |
Huang et al. [31] | 2017 | China | 364/106 | 65 (15) | L3 TAMA, VFA | HGS | 6MWT | 17 | 16.2 | 18.8 |
Lo et al. [32] | 2017 | Taiwan | 689/648 | [65+] | BIA | not included | not included | 24.7 | 24.8 | 24.5 |
Dodds et al. [33] | 2017 | UK | 282/437 | [85+] | BIA | HGS | TUG converted to GS | 20.7 | 20.9 | 20.6 |
Ngeuleu et al. [34] | 2017 | Marocco | 16/107 | 52.3 (13.2) | DXA | not included | not included | 39.8 | 56.3 | 37.4 |
Bianchi et al. [35] | 2017 | Italy | 321/334 | 81 (6.8) [> 65] | BIA | HGS | 4MGS | 34.7 | 36.5 | 32.9 |
Martone et al. [36] | 2017 | Italy | 183/211 | 79.6 (6.4) | BIA | HGS | 4MGS | 14.7 | 15.8 | 13.7 |
Bokshan et al. [37] | 2017 | USA | 26/24 | [55+] | L4 TPA | not included | not included | 32 | 30.7 | 33.3 |
van Vugt et al. [38] | 2018 | Netherlands | 149/75 | [48–62] | L3 TAMA | not included | not included | 24.6 | 24.8 | 24 |
Christensen et al. [39] | 2018 | Denmark | 28/52 | 79 (6.6) [65–94] | DXA | HGS | 10MGS | 26.2 | 28.6 | 25 |
Chen et al. [40] | 2018 | China | 228/148 | 64.33 (12.3) | TAMA, VFA | HGS | 6MWT | 24.5 | 19.3 | 32.4 |
Fung et al. [41] | 2019 | Singapur | 206/181 | 68.3 (5.7) [60–89] | BIA | HGS | 6MGS | 27.4 | 21.8 | 33.7 |
Yang et al. [42] | 2019 | China | 112/204 | [60+] | BIA | HGS | 4MGS | 28.8 | 30.4 | 27.9 |
Our study | Hungary | 0/100 | 67 [50–83] | DXA | HGS | GS | 31 | – | 31 | |